287 related articles for article (PubMed ID: 15888819)
21. Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
Brener SJ; Westerhout CM; Fu Y; Todaro TG; Moliterno DJ; Wagner GS; Granger CB; Armstrong PW;
Am Heart J; 2009 Nov; 158(5):755-60. PubMed ID: 19853693
[TBL] [Abstract][Full Text] [Related]
22. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
[TBL] [Abstract][Full Text] [Related]
23. Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial).
Maioli M; Bellandi F; Leoncini M; Toso A; Dabizzi RP
J Am Coll Cardiol; 2007 Apr; 49(14):1517-24. PubMed ID: 17418289
[TBL] [Abstract][Full Text] [Related]
24. Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial.
Prasad A; Stone GW; Aymong E; Zimetbaum PJ; McLaughlin M; Mehran R; Garcia E; Tcheng JE; Cox DA; Grines CL; Gersh BJ;
Am Heart J; 2004 Apr; 147(4):669-75. PubMed ID: 15077083
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of circulating dead monocytes in patients with acute st-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Tsai TH; Lin YC; Sun CK; Chung SY; Chai HT; Yang CH; Chen SM; Hang CL; Chen CJ; Chua S; Wu CJ; Leu S; Yip HK
Cardiology; 2010; 117(2):131-9. PubMed ID: 20975265
[TBL] [Abstract][Full Text] [Related]
26. Plasma angiopoietin-1 level, left ventricular ejection fraction, and multivessel disease predict development of 1-year major adverse cardiovascular events in patients with acute ST elevation myocardial infarction - a pilot study.
Liu KL; Lin SM; Chang CH; Chen YC; Chu PH
Int J Cardiol; 2015 Mar; 182():155-60. PubMed ID: 25577775
[TBL] [Abstract][Full Text] [Related]
27. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention.
Bellandi F; Maioli M; Gallopin M; Toso A; Dabizzi RP
Catheter Cardiovasc Interv; 2004 Jun; 62(2):186-92. PubMed ID: 15170708
[TBL] [Abstract][Full Text] [Related]
28. Procedural success versus clinical risk status in determining discharge of patients after primary angioplasty for acute myocardial infarction.
Heggunje PS; Harjai KJ; Stone GW; Mehta RH; Marsalese DL; Boura JA; O'Neill WW; Grines CL
J Am Coll Cardiol; 2004 Oct; 44(7):1400-7. PubMed ID: 15464319
[TBL] [Abstract][Full Text] [Related]
29. Role of stromal cell-derived factor-1alpha, level and value of circulating interleukin-10 and endothelial progenitor cells in patients with acute myocardial infarction undergoing primary coronary angioplasty.
Chang LT; Yuen CM; Sun CK; Wu CJ; Sheu JJ; Chua S; Yeh KH; Yang CH; Youssef AA; Yip HK
Circ J; 2009 Jun; 73(6):1097-104. PubMed ID: 19372622
[TBL] [Abstract][Full Text] [Related]
30. [Rapid resolution of ST segment elevation predicts recovery of left myocardial contraction in patients with acute myocardial infarction treated with percutaneous coronary angioplasty].
Tomaszuk-Kazberuk A; Korecki J; Kochman W; Dobrzycki S; Musiał WJ
Przegl Lek; 2002; 59(8):638-41. PubMed ID: 12638338
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
[TBL] [Abstract][Full Text] [Related]
32. Platelet activity is a biomarker of cardiac necrosis and predictive of untoward clinical outcomes in patients with acute myocardial infarction undergoing primary coronary stenting.
Yip HK; Chang LT; Sun CK; Chen MC; Yang CH; Hung WC; Hsieh YK; Fang CY; Hang CL; Wu CJ; Chang HW
Circ J; 2006 Jan; 70(1):31-6. PubMed ID: 16377921
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Lindberg S; Pedersen SH; Møgelvang R; Bjerre M; Frystyk J; Flyvbjerg A; Galatius S; Jensen JS
Am J Cardiol; 2012 Feb; 109(4):492-6. PubMed ID: 22105783
[TBL] [Abstract][Full Text] [Related]
34. Predictive value of postprocedural leukocyte count on myocardial perfusion, left ventricular function and clinical outcomes in ST-elevated myocardial infarction after percutaneous coronary intervention.
He R; Li HY; Guo LJ; Zhang FC; Niu J; Zhang YZ; Wang GS; Yang ZH; Gao W
Chin Med J (Engl); 2012 Mar; 125(6):1023-9. PubMed ID: 22613525
[TBL] [Abstract][Full Text] [Related]
35. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
[TBL] [Abstract][Full Text] [Related]
36. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score.
Halkin A; Singh M; Nikolsky E; Grines CL; Tcheng JE; Garcia E; Cox DA; Turco M; Stuckey TD; Na Y; Lansky AJ; Gersh BJ; O'Neill WW; Mehran R; Stone GW
J Am Coll Cardiol; 2005 May; 45(9):1397-405. PubMed ID: 15862409
[TBL] [Abstract][Full Text] [Related]
37. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ;
Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115
[TBL] [Abstract][Full Text] [Related]
38. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
Sorajja P; Gersh BJ; Cox DA; McLaughlin MG; Zimetbaum P; Costantini C; Stuckey T; Tcheng JE; Mehran R; Lansky AJ; Grines CL; Stone GW
Eur Heart J; 2007 Jul; 28(14):1709-16. PubMed ID: 17556348
[TBL] [Abstract][Full Text] [Related]
39. Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization.
Niccoli G; Lanza GA; Shaw S; Romagnoli E; Gioia D; Burzotta F; Trani C; Mazzari MA; Mongiardo R; De Vita M; Rebuzzi AG; Lüscher TF; Crea F
Eur Heart J; 2006 Aug; 27(15):1793-8. PubMed ID: 16829540
[TBL] [Abstract][Full Text] [Related]
40. Relation between electrocardiographic ST-segment resolution and early and late outcomes after primary percutaneous coronary intervention for acute myocardial infarction.
Brodie BR; Stuckey TD; Hansen C; VerSteeg DS; Muncy DB; Moore S; Gupta N; Downey WE
Am J Cardiol; 2005 Feb; 95(3):343-8. PubMed ID: 15670542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
